scholarly journals Rapid Genome-wide Recruitment of RNA Polymerase II Drives Transcription, Splicing, and Translation Events during T Cell Responses

Cell Reports ◽  
2017 ◽  
Vol 19 (3) ◽  
pp. 643-654 ◽  
Author(s):  
Kathrin Davari ◽  
Johannes Lichti ◽  
Christian Gallus ◽  
Franziska Greulich ◽  
N. Henriette Uhlenhaut ◽  
...  
2013 ◽  
Vol 9 (5) ◽  
pp. e1003303 ◽  
Author(s):  
Julius Clemence R. Hafalla ◽  
Karolis Bauza ◽  
Johannes Friesen ◽  
Gloria Gonzalez-Aseguinolaza ◽  
Adrian V. S. Hill ◽  
...  

2009 ◽  
Vol 83 (21) ◽  
pp. 10981-10992 ◽  
Author(s):  
Young-Hee Jin ◽  
Bongsu Kang ◽  
Byung S. Kim

ABSTRACT Theiler's murine encephalomyelitis virus (TMEV)-induced immune-mediated demyelinating disease in susceptible mouse strains has been extensively investigated as a relevant model for human multiple sclerosis. Previous investigations of antiviral T-cell responses focus on immune responses to viral capsid proteins, while virtually nothing is reported on immune responses to nonstructural proteins. In this study, we have identified noncapsid regions recognized by CD4+ T cells from TMEV-infected mice using an overlapping peptide library. Interestingly, a greater number of CD4+ T cells recognizing an epitope (3D21-36) of the 3D viral RNA polymerase, in contrast to capsid epitopes, were detected in the CNS of TMEV-infected SJL mice, whereas only a minor population of CD4+ T cells from infected C57BL/6 mice recognized this region. The effects of preimmunization and tolerization with these epitopes on the development of demyelinating disease indicated that capsid-specific CD4+ T cells are protective during the early stages of viral infection, whereas 3D21-36-specific CD4+ T cells exacerbate disease development. Therefore, protective versus pathogenic CD4+ T-cell responses directed to TMEV appear to be epitope dependent, and the differences in CD4+ T-cell responses to these epitopes between susceptible and resistant mice may play an important role in the resistance or susceptibility to virally induced demyelinating disease.


2016 ◽  
Vol 6 (1) ◽  
Author(s):  
Mariateresa Coppola ◽  
Krista E. van Meijgaarden ◽  
Kees L. M. C. Franken ◽  
Susanna Commandeur ◽  
Gregory Dolganov ◽  
...  

2013 ◽  
Vol 87 (21) ◽  
pp. 11751-11761 ◽  
Author(s):  
K. Haberthur ◽  
A. Kraft ◽  
N. Arnold ◽  
B. Park ◽  
C. Meyer ◽  
...  

2002 ◽  
Vol 76 (8) ◽  
pp. 3791-3799 ◽  
Author(s):  
Itaru Anraku ◽  
Tracey J. Harvey ◽  
Richard Linedale ◽  
Joy Gardner ◽  
David Harrich ◽  
...  

ABSTRACT The ability of self-replicating RNA (replicon) vaccine vectors derived from the Australian flavivirus Kunjin (KUN) to induce protective αβ CD8+ T-cell responses was examined. KUN replicons encoding a model immunogen were delivered by three different vaccine modalities: (i) as naked RNA transcribed in vitro, (ii) as plasmid DNA constructed to allow in vivo transcription of replicon RNA by cellular RNA polymerase II (DNA based), and (iii) as replicon RNA encapsidated into virus-like particles. A single immunization with any of these KUN replicon vaccines induced CD8+ T-cell responses at levels comparable to those induced by recombinant vaccinia virus encoding the same immunogen. Immunization with only 0.1 μg of DNA-based KUN replicons elicited CD8+ T-cell responses similar to those seen after immunization with 100 μg of a conventional DNA vaccine. Naked RNA immunization with KUN replicons also protected mice against challenges with recombinant vaccinia virus and B16 tumor cells. These results demonstrate the value of KUN replicon vectors for inducing protective antiviral and anticancer CD8+ T-cell responses.


Sign in / Sign up

Export Citation Format

Share Document